Orthopediatrics (KIDS) Rating Increased to Buy at BidaskClub

Share on StockTwits

Orthopediatrics (NASDAQ:KIDS) was upgraded by research analysts at BidaskClub from a “hold” rating to a “buy” rating in a research report issued on Tuesday, BidAskClub reports.

Other research analysts also recently issued reports about the stock. BTIG Research increased their target price on shares of Orthopediatrics to $37.00 and gave the company a “buy” rating in a research report on Wednesday, January 2nd. Zacks Investment Research raised shares of Orthopediatrics from a “hold” rating to a “buy” rating and set a $38.00 target price for the company in a research report on Wednesday, January 2nd. Finally, JMP Securities initiated coverage on shares of Orthopediatrics in a research report on Wednesday, February 20th. They set an “outperform” rating and a $44.00 target price for the company. Seven equities research analysts have rated the stock with a buy rating, The stock has a consensus rating of “Buy” and a consensus price target of $41.00.

NASDAQ:KIDS traded up $0.68 on Tuesday, hitting $41.62. The stock had a trading volume of 402 shares, compared to its average volume of 67,729. The company has a debt-to-equity ratio of 0.26, a quick ratio of 7.77 and a current ratio of 10.54. The firm has a market cap of $598.16 million, a price-to-earnings ratio of -43.35 and a beta of 0.04. Orthopediatrics has a 1 year low of $18.50 and a 1 year high of $47.82.

Orthopediatrics (NASDAQ:KIDS) last posted its quarterly earnings data on Wednesday, March 6th. The company reported ($0.19) EPS for the quarter, meeting the Thomson Reuters’ consensus estimate of ($0.19). The firm had revenue of $14.60 million during the quarter, compared to analyst estimates of $14.50 million. Orthopediatrics had a negative net margin of 20.89% and a negative return on equity of 22.99%. The company’s revenue for the quarter was up 24.8% on a year-over-year basis. During the same quarter last year, the business posted ($1.41) EPS. As a group, sell-side analysts forecast that Orthopediatrics will post -0.41 earnings per share for the current year.

A number of large investors have recently added to or reduced their stakes in KIDS. Sigma Planning Corp bought a new stake in shares of Orthopediatrics during the 1st quarter valued at about $280,000. Rhumbline Advisers raised its holdings in Orthopediatrics by 6.6% in the first quarter. Rhumbline Advisers now owns 9,350 shares of the company’s stock worth $414,000 after buying an additional 580 shares during the last quarter. BNP Paribas Arbitrage SA raised its holdings in Orthopediatrics by 83,150.0% in the first quarter. BNP Paribas Arbitrage SA now owns 1,665 shares of the company’s stock worth $74,000 after buying an additional 1,663 shares during the last quarter. Perkins Capital Management Inc. purchased a new position in Orthopediatrics in the first quarter worth about $221,000. Finally, Conestoga Capital Advisors LLC purchased a new position in shares of Orthopediatrics during the first quarter valued at approximately $440,000. Institutional investors and hedge funds own 44.88% of the company’s stock.

About Orthopediatrics

OrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally. The company's products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail products, PediLoc tibia products, anterior cruciate ligament reconstruction systems, locking cannulated blades, locking proximal femurs, RESPONSE Spine systems, Bandloc, and Pediguard.

Featured Story: The Structure of a Futures Contract

Receive News & Ratings for Orthopediatrics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthopediatrics and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Semmax Financial Advisors Inc. Sells 1,539 Shares of Royal Caribbean Cruises Ltd
Semmax Financial Advisors Inc. Sells 1,539 Shares of Royal Caribbean Cruises Ltd
Vanguard Intermediate-Term Bond ETF  Shares Sold by Semmax Financial Advisors Inc.
Vanguard Intermediate-Term Bond ETF Shares Sold by Semmax Financial Advisors Inc.
Tirschwell & Loewy Inc. Decreases Stake in Verizon Communications Inc.
Tirschwell & Loewy Inc. Decreases Stake in Verizon Communications Inc.
Great Lakes Advisors LLC Has $66.83 Million Stake in Prudential Financial Inc
Great Lakes Advisors LLC Has $66.83 Million Stake in Prudential Financial Inc
Greatmark Investment Partners Inc. Sells 1,835 Shares of BP plc
Greatmark Investment Partners Inc. Sells 1,835 Shares of BP plc
Victory Capital Management Inc. Grows Stake in Evergy
Victory Capital Management Inc. Grows Stake in Evergy


© 2006-2019 Ticker Report